Authors: Goldman GS1, Miller NZ. Abstract In this study, the Vaccine Adverse Event Reporting System (VAERS) database, 1990-2010, was investigated; cases that specified either hospitalization or death were identified among 38,801 reports of infants. Based on the types of vaccines reported, the actual number of vaccine doses administered, from 1 to 8, was summed for […]
Vaccines, adjuvants and autoimmunity
Authors: Luísa Eça Guimarãesa, Britain Bakera, Carlo Perriconeb, Yehuda Shoenfelda,c Abstract Vaccines and autoimmunity are linked fields. Vaccine efficacy is based on whether host immune response against an antigen can elicit a memory T-cell response over time. Although the described side effects thus far have been mostly transient and acute, vaccines are able to elicit the immune system towards […]
HPV vaccination syndrome: A questionnaire-based study
Authors: Manuel Martínez-Lavín, Laura-Aline Martínez-Martínez, Paola Reyes-Loyola Abstract Isolated cases and small series have described the development of complex regional pain syndrome, postural orthostatic tachycardia, and fibromyalgia after human papillomavirus (HPV) vaccination. These illnesses are difficult to diagnose and have overlapping clinical features. Small fiber neuropathy and dysautonomia may play a major role in the pathogenesis of these entities. We […]
CNS demyelination and quadrivalent HPV vaccination
CNS demyelination and quadrivalent HPV vaccination report: Authors: Sutton I1, Lahoria R, Tan I, Clouston P, Barnett M. Abstract Vaccination is generally considered safe in patients with multiple sclerosis (MS). We report five patients who presented with multifocal or atypical demyelinating syndromes within 21 days of immunization with the quadrivalent human papilloma virus (HPV) vaccine, Gardasil. […]
The safety of human papilloma virus blockers
The safety of human papilloma virus blockers and the risk of triggering autoimmune diseases Authors: Baker B1, Eça Guimarães L, Tomljenovic L, Agmon-Levin N, Shoenfeld Y. Abstract INTRODUCTION: With the safety of human papilloma virus vaccine (HPVv) being questioned, this article aims to assess the risks and benefits of the commercially available HPVv. Within the last […]
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 60
- Next Page »